Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
MYLAN-NITRO SUBLINGUAL SPRAY MYLAN PHARMACEUTICALS ULC Actual shortage 0.4MG Updated Report 2024-05-03 181369
PROPOFOL INJECTION BAXTER CORPORATION Avoided shortage 10MG Updated Report 2024-05-03 210580
PROPOFOL INJECTION BAXTER CORPORATION Avoided shortage 10MG Updated Report 2024-05-03 210586
XARELTO BAYER INC Anticipated shortage 10MG Updated Report 2024-05-03 226202
ALIMTA ELI LILLY CANADA INC Actual shortage 100MG Updated Report 2024-05-03 226352
POSANOL MERCK CANADA INC Actual shortage 100MG Updated Report 2024-05-03 222593
CANDESARTAN-HCTZ PRO DOC LIMITEE Anticipated shortage 12.5MG 16.0MG New Report 2024-05-03 227037
APO-PANTOPRAZOLE APOTEX INC Actual shortage 20MG Updated Report 2024-05-03 227034
APO-VALACYCLOVIR APOTEX INC Actual shortage 500MG Updated Report 2024-05-03 227031
APO-BRIMONIDINE-TIMOP APOTEX INC Actual shortage 0.5% 0.2% New Report 2024-05-03 227028

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
CHAMPIX PFIZER CANADA ULC Discontinued 1MG 0.5MG New Report 2024-05-03 227052
CHAMPIX PFIZER CANADA ULC Discontinued 1MG New Report 2024-05-03 227049
CHAMPIX PFIZER CANADA ULC Discontinued 0.5MG New Report 2024-05-03 227046
AUBAGIO SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC To be discontinued 14MG New Report 2024-05-02 226847
SANDOZ OXYCODONE/ACETAMINOPHEN SANDOZ CANADA INCORPORATED Discontinued 325MG 5MG Updated Report 2024-05-02 226748